3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other solid neoplasm
1
Conditions
Carcinoma, Non-Small-Cell Lung
2
Solid Tumour
1
Neoplasm Metastasis
1
Interventions
L19-IL2 immunocytokine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Solid Tumour
×
L19-IL2 immunocytokine
×
Clear all
NCT02086721
2017-05-31
L19-IL2
Maastricht Radiation Oncology
Phase 1
Completed
18 enrolled